|
(11) | EP 1 746 984 A2 |
(12) |
|
|
|
|
|||||||||||||||||||||||
(54) | USE OF TARGETED OXIDATIVE THERAPEUTIC FORMULATION IN TREATMENT OF DIABETES AND OBESITY |